What does APOTHEEK DE LIEVE do?

APOTHEEK DE LIEVE is a pharmacy in Lievegem. Private Limited, started on 9 December 2008, 1 establishment.

What is the address of APOTHEEK DE LIEVE?

The registered office of APOTHEEK DE LIEVE is located at Grote Baan 291, 9930 Lievegem.

Is APOTHEEK DE LIEVE still active?

Yes. According to the CBE (31 October 2026) APOTHEEK DE LIEVE is active, legal situation “Normale toestand”, started on 9 December 2008.

Is APOTHEEK DE LIEVE registered on Peppol?

Yes, APOTHEEK DE LIEVE is registered on the Peppol network with ID 0208:0808285756.

What is the enterprise number of APOTHEEK DE LIEVE?

The enterprise number of APOTHEEK DE LIEVE is BE0808285756.

When was APOTHEEK DE LIEVE founded?

APOTHEEK DE LIEVE was founded on 9 December 2008.

Who are the directors of APOTHEEK DE LIEVE?

According to the 2026 annual accounts, the directors of APOTHEEK DE LIEVE are: Rijckaert Invest BV.

Is APOTHEEK DE LIEVE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 9 December 2008; 5 annual accounts filed, latest fiscal year 2026; 1 directors known from the annual account.

How much profit did APOTHEEK DE LIEVE make in 2026?

APOTHEEK DE LIEVE posted a profit after taxes of € 12,338 in financial year 2026.

What is the revenue of APOTHEEK DE LIEVE?

As a small company, APOTHEEK DE LIEVE is not required to publish revenue in its annual accounts. In financial year 2026, its added value was € -1,232.

APOTHEEK DE LIEVE (Private Limited) - Lievegem

Dossier APOTHEEK DE LIEVE, printed on 31 October 2026 from databakkes.be/en/0808285756/apotheek-de-lieve. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 55 % of short-term debt in 2026; threshold 65 %.

Financials

Financial year 2026

APOTHEEK DE LIEVE from Lievegem, company number BE0808285756, closed financial year 2026 with a result of € 12,338 after tax. For that financial year APOTHEEK DE LIEVE recorded a gross margin of € -1,232 and equity of € 153,888. Compared with financial year 2025, the result moved from € -18,173 to € 12,338. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 27, 2026.

What it is worth Growing

€ 153,888

▲ 9% vs 2025

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 12,338

▲ still € 18,173 loss in 2025

Profit after tax over the fiscal year.

Cash in the bank

€ 130,111

▲ 64% vs 2025

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2026. Retained profit grew to € 40,888.

People and assets in 2026

Vehicles and equipment

€ 6,201

▲ 87% vs 2025

Book value of vehicles, furniture and equipment.

Debts at end 2026

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 59,593

▼ 1% vs 2025

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 3,676

▲ 13% vs 2025

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	2026	Change 2025 → 2026
Gross margin	€ 13,651 Gross margin 2023: € 13,651 First fiscal year in the series	€ -43,957 Gross margin 2024: € -43,957 ▼ € 57,608 vs 2023 (€ 13,651) Unfavourable step	€ -34,116 Gross margin 2025: € -34,116 ▲ € 9,841 vs 2024 (€ -43,957) Favourable step	€ -1,232 Gross margin 2026: € -1,232 ▲ € 32,884 vs 2025 (€ -34,116) Favourable step	▲ € 32,884
Profit after taxes	€ 17,795 Profit after taxes 2023: € 17,795 First fiscal year in the series	€ -13,706 Profit after taxes 2024: € -13,706 ▼ € 31,501 vs 2023 (€ 17,795) Unfavourable step	€ -18,173 Profit after taxes 2025: € -18,173 ▼ € 4,467 vs 2024 (€ -13,706) Unfavourable step	€ 12,338 Profit after taxes 2026: € 12,338 ▲ € 30,511 vs 2025 (€ -18,173) Favourable step	▲ € 30,511
Equity	€ 173,429 Equity 2023: € 173,429 First fiscal year in the series	€ 159,723 Equity 2024: € 159,723 ▼ 8% vs 2023 (€ 173,429) Unfavourable step	€ 141,550 Equity 2025: € 141,550 ▼ 11% vs 2024 (€ 159,723) Unfavourable step	€ 153,888 Equity 2026: € 153,888 ▲ 9% vs 2025 (€ 141,550) Favourable step	▲ 9%
Total debts	€ 134,561 Total debts 2023: € 134,561 First fiscal year in the series	€ 122,231 Total debts 2024: € 122,231 ▼ 9% vs 2023 (€ 134,561) Favourable step	€ 242,070 Total debts 2025: € 242,070 ▲ 98% vs 2024 (€ 122,231) Unfavourable step	€ 264,448 Total debts 2026: € 264,448 ▲ 9% vs 2025 (€ 242,070) Unfavourable step	▲ 9%
Cash	€ 138,654 Cash 2023: € 138,654 First fiscal year in the series	€ 45,703 Cash 2024: € 45,703 ▼ 67% vs 2023 (€ 138,654) Unfavourable step	€ 79,188 Cash 2025: € 79,188 ▲ 73% vs 2024 (€ 45,703) Favourable step	€ 130,111 Cash 2026: € 130,111 ▲ 64% vs 2025 (€ 79,188) Favourable step	▲ 64%
Land & buildings	€ 1,267 Land & buildings 2023: € 1,267 First fiscal year in the series	€ 806 Land & buildings 2024: € 806 ▼ 36% vs 2023 (€ 1,267) Unchanged	€ 346 Land & buildings 2025: € 346 ▼ 57% vs 2024 (€ 806) Unchanged	€ 0 Land & buildings 2026: € 0 ▼ 100% vs 2025 (€ 346) Unchanged	▼ 100%
Retained profit	€ 60,429 Retained profit 2023: € 60,429 First fiscal year in the series	€ 46,723 Retained profit 2024: € 46,723 ▼ 23% vs 2023 (€ 60,429) Unfavourable step	€ 28,550 Retained profit 2025: € 28,550 ▼ 39% vs 2024 (€ 46,723) Unfavourable step	€ 40,888 Retained profit 2026: € 40,888 ▲ 43% vs 2025 (€ 28,550) Favourable step	▲ 43%
Balance sheet total	€ 307,991 Balance sheet total 2023: € 307,991 First fiscal year in the series	€ 281,954 Balance sheet total 2024: € 281,954 ▼ 8% vs 2023 (€ 307,991) Unchanged	€ 383,620 Balance sheet total 2025: € 383,620 ▲ 36% vs 2024 (€ 281,954) Unchanged	€ 418,337 Balance sheet total 2026: € 418,337 ▲ 9% vs 2025 (€ 383,620) Unchanged	▲ 9%

Key figures of APOTHEEK DE LIEVE, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.

What happened to APOTHEEK DE LIEVE?

What happened at APOTHEEK DE LIEVE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 27, 2026 New annual accounts for financial year 2026: profit of € 12,338. Source: NBB ↗
2016 Rijckaert Invest BV became a director. NBB
Dec 9, 2008 Start of the company according to the CBE. KBO
Dec 8, 2008 New establishment in Lievegem. KBO

In short

From € 17,795 profit in 2023 to € 12,338 profit in 2026.

Paid € 8,239 in corporate taxes since 2023.

Best year ever: 2023, with € 17,795 profit.

Original PDFs at the National Bank ↗

Management

RIJCKAERT INVEST 100%

The stake of RIJCKAERT INVEST comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK DE LIEVE

Behind APOTHEEK DE LIEVE is Rijckaert Invest BV. The shares are held by RIJCKAERT INVEST (100%).

Directors

According to the 2026 annual accounts

Rijckaert Invest BV

Director · represented by Rijckaert Lien

since 2016

Shareholders

RIJCKAERT INVEST

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Grote Baan 291

9930 Lievegem

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

RIJCKAERT INVEST same network

€ 142,796 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0808.285.756

VAT number

BE 0808.285.756

Registered office

Grote Baan 291, 9930 Lievegem

Names & denominations

APOTHEEK DE LIEVE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

9 December 2008

Peppol

Active · Active since 13 May 2025

Activities · NACE

Detailhandel in farmaceutische producten

Vervaardiging van gehomogeniseerde voedingspreparaten en dieetvoeding

Vervaardiging van geneesmiddelen

Detailhandel in drogisterijartikelen en onderhoudsproducten

Overige zakelijke dienstverlening, neg

Vervaardiging van farmaceutische grondstoffen

Detailhandel in drogisterijartikelen en onderhoudsproducten in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK DE LIEVE

Warning lights

Financials

What happened to APOTHEEK DE LIEVE?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions